Treatment of duchenne muscular dystrophy

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 231/56 (2006.01) A61K 31/416 (2006.01) A61P 21/00 (2006.01) C07D 249/20 (2006.01)

Patent

CA 2685582

There are provided compounds of Formula (I) wherein three of A1, A2, A3, and A4 represent CH and one of A1, A2, A3, and A4 represents CR1; R1 represents SO2R2 or NHCOR2 wherein R2 represents C1-C6 alkyl optionally substituted by one or more halogen, hydroxyl or alkoxy groups; R9 represents C6-C10 aryl; or a pharmaceutically acceptable salt thereof and method of treatment of Duchenne muscular dystrophy.

L'invention concerne des composés de la formule (I) dans laquelle trois éléments parmi A1, A2, A3, et A4 représentent CH et un élément parmi A1, A2, A3, et A4 représente CR1; R1 représente SO2R2 ou NHCOR2 où R2 représente un C1-C6 alkyle facultativement substitué par un ou plusieurs groupes halogène, hydroxyle ou alcoxy; R9 représente un C6-C10 aryle; ou un sel pharmaceutiquement acceptable de ces derniers.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of duchenne muscular dystrophy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of duchenne muscular dystrophy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of duchenne muscular dystrophy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1602123

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.